GCAVX — GMO U.S. Small Cap Value Fund
Data updated: 2026-07-29
GCAVX — GMO U.S. Small Cap Value Fund data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Small Cap Blend / Core Equity · $45.29M AUM · 0.50% expense ratio · 39.0% 1-yr return. From SEC regulatory filings.
GCAVX Fund Overview
GCAVX — GMO U.S. Small Cap Value Fund is a US mutual fund managed by Gmo Trust, categorised as United States Small Cap Blend / Core Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Gmo Trust
- Category: United States Small Cap Blend / Core Equity
- Assets under management: $45.29M
- 1-year return: 39.0%
- Ticker: GCAVX
- SEC CIK: 0000772129
- SEC series ID: S000065871
- Share class ID: C000212810
GCAVX Holdings
Top 10 holdings of GMO U.S. Small Cap Value Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| BorgWarner Inc | 2.44% |
| Axcelis Technologies Inc | 2.27% |
| Skyworks Solutions Inc | 1.91% |
| ArcBest Corp | 1.89% |
| Enova International Inc | 1.85% |
| Cirrus Logic Inc | 1.84% |
| Lear Corp | 1.72% |
| Lincoln National Corp | 1.68% |
| Jackson Financial Inc | 1.68% |
| Macy's Inc | 1.64% |
GCAVX Portfolio Allocation
Asset-class allocation of GMO U.S. Small Cap Value Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.7% |
| Cash & Equivalents | 0.4% |
GCAVX Performance
Total returns for GCAVX (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | 14.4% |
| 1 year | 39.0% |
| 3 years (annualised) | 22.3% |
| 5 years (annualised) | 10.0% |
GCAVX Risk Information
Risk metrics for GCAVX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 13.6%
GCAVX Costs and Fees
GCAVX costs about $50 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.50%
- Gross expense ratio: 0.69%
- Portfolio turnover: 98%
- Brokerage commissions: 3.08 bps of average net assets (SEC N-CEN)
GCAVX Cashflows
Over the 12 months to 2026-02, GMO U.S. Small Cap Value Fund had net inflows of $334.40K, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-02 | $350.00K |
| 2026-01 | $0 |
| 2025-12 | $1.02M |
| 2025-11 | −$899.73K |
| 2025-10 | −$405.00K |
| 2025-09 | $0 |
GCAVX Debt Constituents
No individual debt constituents are reported in GMO U.S. Small Cap Value Fund's latest SEC N-PORT filing.
GCAVX Prospectus and SEC Filings
Official GMO U.S. Small Cap Value Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Small Cap Blend / Core Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.